Announcements Trials
Browse Landscape

Phase

Phase 3 13Phase 2 5Phase 4 4Phase 2/3 1Phase 1 1

Status

Terminated 3Completed 1

Sponsor Class

OTHER 22INDUSTRY 4

Study Type

Interventional 4

Sponsor

Conditions

Pain 2Cancer Pain 2Chronic Pain 1Breakthrough Pain 1Agnosia 1

Interventions

Zoledronic Acid 23Bevacizumab 13nilotinib 12Docetaxel 12Paclitaxel 11Everolimus 11Letrozole 10Imatinib Mesylate 10Capecitabine 10Erlotinib Hydrochloride 9Drug Therapy 9Carboplatin 9pegfilgrastim 8enzalutamide 8Trastuzumab 7Oxycodone 7Nivolumab 7Imiquimod 7Gemcitabine 7Epoetin Alfa 7icotinib 6Rituximab 6Prednisone 6Pemetrexed 6Oxaliplatin 6Leuprolide 6Fulvestrant 6Diclofenac 6Dexamethasone 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Fentanyl × Clear all
NCT01315886 2017-04-05

Conversion From Fast Acting Oral Opioids to Abstral®

Orexo AB

Phase 4 Terminated
8 enrolled

Pain

NCT01902524 2014-08-28

Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain

Janssen Korea, Ltd., Korea

Phase 4 Completed
65 enrolled

Chronic Pain

NCT00842829 2012-10-01

Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 4 Terminated
330 enrolled 32 charts

Cancer Pain, Breakthrough Pain

NCT00236327 2011-05-17

Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain

Janssen Cilag S.A.S.

Phase 4 Terminated
34 enrolled

Cancer Pain, Agnosia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡